Bu nedenle GLP-1i desteklemek, kilo ynetimi iin faydal bir strateji olabilir
Joint pain during tirzepatide therapy is usually caused by mechanical stress from rapid weight loss, temporary inflammation during tissue adaptation, or loss of muscle support around joints
Preliminary investigations of GLP-1 agents in patients with both conditions have reported modest improvements in inflammatory markers, though these studies are small and not designed to establish efficacy for RA
The study also highlighted that adverse effects were reported in approximately 50% of the cohort during follow-up, with gastrointestinal symptoms being the most commonly reported adverse effects, including nausea and vomiting
At AgeWell Medicine & Aesthetics, we offer ongoing support and monitoring to ensure that the treatment is working effectively for you, helping you achieve sustainable weight loss
Our clinical experience extends to helping patients understand the lesser-known GLP-1 benefits that may improve their health outcomes